Remote And Decentralised Innovative Approaches to Clinical Trials (RADIAL)

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 107 participants.

Also called NCT05780151

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose other
Phase
Phase 4
Enrolled
  • 107 participants (enrolled count) (from the registry)
Sponsor
  • Sanofi Registry lists this organization as a collaborator
Registry
  • NCT NCT05780151
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Denmark, Germany, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05780151. Randomized; no masking; primary purpose other. Start 2023-07-10 (actual); primary completion 2025-01-21 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Remote And Decentralised Innovative Approaches to Clinical Trials (RADIAL)
Acronym
RADIAL
Condition
Diabetes Mellitus, Type 2
Intervention (Other)
Methodological intervention
Intervention (Drug)
Toujeo
Lead sponsor
Mira Zuidgeest (class: other)
Collaborator
IMI Trials@Home consortium (class: not stated)
Collaborator
Innovative Medicines Initiative (class: other)
Collaborator
Sanofi (class: industry)

Record details

Record id
cardio:ct-nct05780151
Content hash
4d0d15802163026387c0a8a55eef49c01fda52945935bf42520a554588cc4333